Pharmafile Logo
Pharmafocus logo
Advanced Search

biotech

Showing 15 posts of 861 posts found.

Can European biotech stay afloat?

June 1, 2009
Research and Development biotech, economic climate, funding, investment

For the European biotech industry, the last few years have seen sustained growth across several fronts – much-needed progress after …

Feature

UK government ignores biotech pleas for cash

May 27, 2009
Research and Development biotech

The UK biotech sector says the government's failure to provide urgently needed financial assistance is jeopardising its future.Industry body the …

News

Biotech partnering in the credit crunch

May 1, 2009
Research and Development biotech, partnering, pharma

Action Pharma’s Torben Jung Laursen explores the new challenges facing pharma-biotech partnering as a result of the economic downturn.In today’s …

Feature

Merck Serono sets up biotech fund

March 24, 2009
Research and Development Merck Serono, biotech

Merck Serono has set up a venture capital fund to invest in emerging biotech companies working in its core therapy …

News

One in five European biotech companies facing bankruptcy

March 17, 2009
Research and Development biotech

Around one in five European biotech companies could go bust by the end of 2009 if new funding doesn't emerge …

News

Oxford BioMedica looks to move on from a challenging 2008

March 13, 2009
Sales and Marketing Oxford BioMedica, biotech

News

UK Biotech: time for bold and affirmative action

January 22, 2009
Research and Development, Sales and Marketing BTG, Chris Collins, Christopher Evans, Neuropharm, Plethora, UK, biotech, pharma, strategy

Biotech leaders in the UK say the cash-stricken industry has reached ‘breaking point’, and have made an unprecedented plea for …

Feature

UK biotech forced to hang on for government aid

January 9, 2009
Research and Development biotech

Cash-stricken UK biotech has been left hanging on for government funding, without any guarantee it will get the support needed. …

News

Biotech in 2008

December 31, 2008
Research and Development Genentech, InClone, biotech, economy, investment

The credit crunch hits biotechBy October Europe's biotech sector was feeling severe effects from the credit crunch, with small and …

Feature

UK biotech seeks bail out

December 9, 2008
Research and Development biotech

Biotech leaders in the UK say the cash-stricken industry has reached 'breaking point', and have made an unprecedented plea for …

News

Leaders use war gaming to strengthen UK biotech

October 22, 2008
Research and Development, Sales and Marketing biotech

Bioscience leaders from both sides of the Atlantic have joined in a war game that could help boost the UK …

News

Oxford BioMedica fills leadership vacancy

October 14, 2008
Research and Development, Sales and Marketing biotech

Oxford BioMedica has settled on a permanent chief executive, promoting John Dawson from his acting leadership position. Chairman professor Alan …

News

Credit crunch hits European biotech

October 1, 2008
Research and Development 2008, YIR, biotech

Europe’s biotech sector is being hit hard by the credit crunch, with small and medium-sized companies being starved of funding …

News

Latest news from Datamonitor

September 23, 2008
biotech

Monoclonal antibody sales to almost double by 2013In 2007, total global monoclonal antibody sales reached $26 billion and are forecast …

News

Amgen sells off two biotech products

September 16, 2008
Research and Development biotech

Biotech pioneer Amgen has sold off two niche products to Biovitrum, along with the promotional rights to a third product, …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025